MORGAN STANLEY PLC/CALL/ZOETIS/280/0.1/19.12.25 | Market Closed - Bid/Ask 19:38:46 03/06/2024 BST | After market 20:48:29 | |||
| 0.71 EUR | +4.41% |
|
0.715 | +0.70% |
| 1 month | +3.03% | ||
| 3 months | -41.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 0.71 | +4.41% |
| 31/05/24 | 0.68 | -2.86% |
| 30/05/24 | 0.7 | -7.89% |
| 29/05/24 | 0.76 | +5.56% |
| 28/05/24 | 0.72 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 03, 2024 at 07:38 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB9BGZ |
| ISIN | DE000MB9BGZ5 |
| Date issued | 01/08/2023 |
| Strike | 280 $ |
| Maturity | 19/12/2025 (564 Days) |
| Parity | 10 : 1 |
| Emission price | 0.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.1 € |
|---|---|
| Lowest since issue | 0.49 € |
| Spread | 0.01 € |
| Spread % | 1.39% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
169.6
USD
Average target price
211.2
USD
Spread / Average Target
+24.56%
- Stock Market
- Warrants
- Warrant